Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin

被引:130
作者
Damge, C
Vranckx, H
Balschmidt, P
Couvreur, P
机构
[1] UNIV PARIS 11,FAC PHARM,F-92290 CHATENAY MALABR,FRANCE
[2] NOVO NORDISK AS,DK-2880 BAGSVAERD,DENMARK
[3] UCB PHARMA,BRAINE LALLEUD,BELGIUM
关键词
D O I
10.1021/js970124i
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Poly(alkyl cyanoacrylate) nanocapsules have been successfully used for oral administration of insulin in diabetic rats. This work reports a suitable formulation for insulin-loaded nanospheres composed of full polymeric structures for med by polymerization of isobutyl cyanoacrylate (IBCA) in an acidic medium, insulin (15 U/mL) being added to the polymerization medium 60 min after the onset of polymerization. These nanospheres (MW 364) displayed a mean size of 145 nm and an association rate of 1 U of insulin/mg of polymer. They protected insulin from the degradation by proteolytic enzymes in vitro, especially when they were dispersed in an oily medium (Miglyol 812) containing surfactive agents (Poloxamer 188 and deoxycholic acid). When dispersed in the same medium, insulin-loaded nanospheres (100 U/kg of body weight), administered perorally in streptozotocin-induced diabetic rats, provoked a 50% decrease of fasted glycemia from the second hour up to 10-13 days. This effect was shorter (2 days) or absent when nanospheres were dispersed in water with surfactive agents or not. Using C-14-labeled nanospheres loaded with [I-125]insulin, it was found that nanospheres increased the uptake of [I-125]insulin or its metabolites in the gastrointestinal tract, blood, and liver while the excretion was delayed when compared to [I-125]insulin nonassociated to nanospheres; in addition, C-14- and I-125-radioactivities disappeared progressively as a function of time, parallel to the biological effect. Thus insulin-loaded nanospheres can be considered as a convenient delivery system for oral insulin at the prerequisite that they were dispersed in an oily phase containing surfactants.
引用
收藏
页码:1403 / 1409
页数:7
相关论文
共 53 条
[1]   JEJUNAL-ABSORPTION, PHARMACOLOGICAL ACTIVITY, AND PHARMACOKINETIC EVALUATION OF INDOMETHACIN-LOADED POLY(D,L-LACTIDE) AND POLY(ISOBUTYL-CYANOACRYLATE) NANOCAPSULES IN RATS [J].
AMMOURY, N ;
FESSI, H ;
DEVISSAGUET, JP ;
DUBRASQUET, M ;
BENITA, S .
PHARMACEUTICAL RESEARCH, 1991, 8 (01) :101-105
[2]   TRANSMUCOSAL PASSAGE OF POLYALKYLCYANOACRYLATE NANOCAPSULES AS A NEW DRUG CARRIER IN THE SMALL-INTESTINE [J].
APRAHAMIAN, M ;
MICHEL, C ;
HUMBERT, W ;
DEVISSAGUET, JP ;
DAMGE, C .
BIOLOGY OF THE CELL, 1987, 61 (1-2) :69-76
[3]   ABSORPTION CHARACTERISTICS OF CHEMICALLY MODIFIED-INSULIN DERIVATIVES WITH VARIOUS FATTY-ACIDS IN THE SMALL AND LARGE-INTESTINE [J].
ASADA, H ;
DOUEN, T ;
WAKI, M ;
ADACHI, S ;
FUJITA, T ;
YAMAMATO, A ;
MURANISHI, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (06) :682-687
[4]   ENTERAL ADMINISTRATION OF INSULIN IN THE RAT [J].
BARON, H ;
BERRY, EM ;
ELDOR, A ;
KIDRON, M ;
LICHTENBERG, D ;
ZIV, E .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (01) :21-24
[5]  
BECK PH, 1994, EUR J PHARM BIOPHARM, V40, P134
[6]   MORPHO-CYTOCHEMICAL AND BIOCHEMICAL-EVIDENCE FOR INSULIN ABSORPTION BY THE RAT ILEAL EPITHELIUM [J].
BENDAYAN, M ;
ZIV, E ;
BENSASSON, R ;
BARON, H ;
KIDRON, M .
DIABETOLOGIA, 1990, 33 (04) :197-204
[7]   BIOCHEMICAL AND MORPHO-CYTOCHEMICAL EVIDENCE FOR THE INTESTINAL-ABSORPTION OF INSULIN IN CONTROL AND DIABETIC RATS - COMPARISON BETWEEN THE EFFECTIVENESS OF DUODENAL AND COLON MUCOSA [J].
BENDAYAN, M ;
ZIV, E ;
GINGRAS, D ;
BENSASSON, R ;
BARON, H ;
KIDRON, M .
DIABETOLOGIA, 1994, 37 (02) :119-126
[8]   IMPROVEMENT OF SYSTEMIC ABSORPTION OF INSULIN THROUGH EYES WITH ABSORPTION ENHANCERS [J].
CHIOU, GCY ;
CHUANG, CY .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (10) :815-818
[9]  
CHO YW, 1989, LANCET, V2, P1518
[10]   POLYALKYLCYANOACRYLATE NANOPARTICLES AS DRUG CARRIER - PRESENT STATE AND PERSPECTIVES [J].
COUVREUR, P ;
VAUTHIER, C .
JOURNAL OF CONTROLLED RELEASE, 1991, 17 (02) :187-198